Scale-up of technologies for the production of stem cells and stem cell-derived disease models

Our proposal looks to expand the capability of NCRIS Phenomics Australia In Vitro GenomeEngineering & Disease Modelling network in NSW. The acquisition of bioreactors will allowus to produce stem cells and stem cell products reproducibly, and at scale at our only NSWnode. This investment will support broad research applications from disease modellingand stem cell therapy, to drug discovery so spans both the Material/Chemistry andBiotechnology themes of the NSW 20-Year R&D Roadmap, aligning with the PersonalisedMedicine and Pharmaceutical and Neutraceuticals competitive advantage areas.